Galectin Therapeutics (GALT) Intangibles (2010 - 2016)
Galectin Therapeutics (GALT) posted Intangibles of $1,000 for Q4 2016, down 87.5% from $8,000 a year earlier and down 66.7% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Intangibles (2010 - 2016) Analysis & Trends
Since Q4 2010, Galectin Therapeutics has reported Intangibles for 24 quarters.
- Annual Intangibles has declined for six consecutive years, with a five-year compound annual growth rate of -51.2% (FY2011 to FY2016).
- In prior years, Galectin Therapeutics' Intangibles was $8,000 in FY2015 (-46.7%), $15,000 in FY2014 (-34.8%), $23,000 in FY2013 (-23.3%) and $30,000 in FY2012 (-16.7%).
- The Q4 2016 figure stands as the lowest quarterly Intangibles in data going back to Q4 2010.
- On a year-over-year basis, Intangibles has declined in each of the last 19 quarters, with an average decline of 53.0% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 10.5% (Q2 2012) and 87.5% (Q4 2016) over the last five years.
- According to Business Quant data, Intangibles for the three prior quarters was $3,000 (Q3 2016), $5,000 (Q2 2016) and $7,000 (Q1 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Galectin Therapeutics | 224.13 Mn | 167.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 1,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 5,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Dec 31, 2015 | 8,000.00 |
| Sep 30, 2015 | 10,000.00 |
| Jun 30, 2015 | 12,000.00 |
| Mar 31, 2015 | 14,000.00 |
| Dec 31, 2014 | 15,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 23,000.00 |
| Sep 30, 2013 | 24,000.00 |
| Jun 30, 2013 | 26,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 30,000.00 |
| Sep 30, 2012 | 33,000.00 |
| Jun 30, 2012 | 34,000.00 |
| Mar 31, 2012 | 35,000.00 |
API Access
Galectin Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();